Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2016 September;58(3) > Panminerva Medica 2016 September;58(3):242-3

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints
Cite this article as

PANMINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

LETTERS TO THE EDITOR  


Panminerva Medica 2016 September;58(3):242-3

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry

Andrea RUBBOLI 1, Cataldo PALMIERI 2, Giancarlo PIOVACCARI 3, Giuseppe DI PASQUALE 4, Carlo BRIGUORI 5, Massimo MARGHERI 6 , for the WARfarin and coronary STENTing (WAR-STENT) Study Group 

1 Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Bologna, Italy; 2 Division of Cardiology, Ospedale del Cuore “G. Pasquinucci”, Massa, Italy; 3 Division of Cardiology, Ospedale degli Infermi, Rimini, Italy; 4 Division of Cardiology, Ospedale Maggiore, Bologna, Italy; 5 Department of Cardiology, Clinica Mediterranea, Napoli, Italy; 6 Department of Cardiology, Ospedale S. Maria delle Croci, Ravenna, Italy


PDF  


top of page

Publication History

Cite this article as

Rubboli A, Palmieri C, Piovaccari G, Di Pasquale G, Briguori C, Margheri M; WARfarin and coronary STENTing (WAR-STENT) Study Group. Changes in antithrombotic therapy after a cerebrovascular or coronary ischemic event in the WARfarin and coronary STENTing (WAR-STENT) registry. Panminerva Med 2016 September;58(3):242-3. 

for the WARfarin and coronary STENTing (WAR-STENT) Study Group

Corresponding author e-mail

andrearubboli@libero.it.